6-Hydroxydopamine: a far from simple neurotoxin

被引：42
|
作者：
Vareslija, Damir [1 ,2 ]
Tipton, Keith F. [1 ]
Davey, Gavin P. [1 ]
McDonald, Andrew G. [1 ]
机构：
[1] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland
[2] Royal Coll Surgeons Ireland, Dept Surg, York House, York St, Dublin, Ireland
来源：
JOURNAL OF NEURAL TRANSMISSION | 2020年 / 127卷 / 02期
基金：
爱尔兰科学基金会;
关键词：
Neurotoxicity; Aminochrome; Apoptosis; Autoxidation; Dopamine; Highly reactive oxygen species (hROS); 4-Hydroxynonenal; Mitochondria; Iron release; Necrosis; Oxidative damage; Parkinson's disease; Peroxynitrite; Reactive oxygen species (ROS); NEURONAL CELL-DEATH; CATECHOL-O-METHYLTRANSFERASE; UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; MONOAMINE-OXIDASE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; OXIDATIVE STRESS; COMPLEX-I;
D O I：
10.1007/s00702-019-02133-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
6-Hydroxydopamine (6-OHDA), which is a neurotoxin that selectively destroys catecholaminergic nerves in sympathetically innervated tissues, has been used to provide a model of Parkinson's disease in experimental animals. It is rapidly autoxidised to yield potentially toxic products and reactive oxygen species. Its ability to release Fe(II) from protein storage sites also results in the formation of hROS. This account will consider how this family of toxic products may contribute to the observed effects of 6-OHDA.
引用
收藏
页码：213 / 230
页数：18
相关论文
共 50 条
  • [31] PREVENTION OF 6-HYDROXYDOPAMINE NEUROTOXICITY
    COHEN, G
    ALLIS, B
    WINSTON, B
    MYTILINEOU, C
    HEIKKILA, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 33 (01) : 217 - 221
  • [32] 6-HYDROXYDOPAMINE THERAPY IN GLAUCOMA
    WATANABE, H
    LEVENE, RZ
    BERNSTEIN, MR
    TRANSACTIONS AMERICAN ACADEMY OF OPHTHALMOLOGY AND OTOLARYNGOLOGY, 1976, 81 (04): : P127 - P127
  • [33] NEW SYNTHESIS OF 6-HYDROXYDOPAMINE
    WEHRLI, PA
    CHU, V
    PIGOTT, F
    CANADIAN JOURNAL OF CHEMISTRY, 1972, 50 (18): : 3075 - &
  • [34] EFFECT OF 6-HYDROXYDOPAMINE ON HEMOGLOBIN
    MCGIRL, A
    FEELY, S
    OREGAN, RG
    DOOLEY, E
    IRISH JOURNAL OF MEDICAL SCIENCE, 1986, 155 (09) : 333 - 334
  • [35] Iron protects astrocytes from 6-hydroxydopamine toxicity
    Raicevic, N
    Mladenovic, A
    Perovic, M
    Harhaji, L
    Miljkovic, D
    Trajkovic, V
    NEUROPHARMACOLOGY, 2005, 48 (05) : 720 - 731
  • [36] 6-HYDROXYDOPAMINE AND STRIATAL ACETYLCHOLINE LEVELS
    GREWAAL, DS
    FIBIGER, HC
    MCGEER, EG
    BRAIN RESEARCH, 1974, 73 (02) : 372 - 375
  • [37] ENHANCEMENT OF AUDIOGENIC SEIZURE BY 6-HYDROXYDOPAMINE
    BOURN, WM
    CHIN, L
    PICCHION.AL
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1972, 24 (11) : 913 - &
  • [38] EFFECTS OF 6-HYDROXYDOPAMINE ON CAT RETINA
    SPIGUEL, RD
    GUTIERRE.O
    ACTA PHYSIOLOGICA LATINOAMERICANA, 1973, 23 (03) : 70 - 70
  • [39] INTRACISTERNAL 6-HYDROXYDOPAMINE AND SLEEP IN RAT
    MATSUYAMA, S
    COINDET, J
    MOURET, J
    BRAIN RESEARCH, 1973, 57 (01) : 85 - 95
  • [40] POTENTIATION OF LEPTAZOL SEIZURES BY 6-HYDROXYDOPAMINE
    CORCORAN, ME
    FIBIGER, HC
    MCGEER, EG
    WADA, JA
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (06) : 497 - 499
12345